Abstract:Introduction: Human pluripotent stem cells (hPSC)-derived cardiac organoids (COs) have gained increasing interest in biotechnology due to their characteristics like diverse cardiovascular cell types, 3D complex structure, and function that recapitulates the human heart in early development. However, current methods for vascularizing COs are not systematic and robust. Hypothesis: We hypothesize that culturing hPSC-derived COs dynamically will further enhance vascularization in COs. Materials and Methods: Two conditions were created to compare vascularization in COs: 1) dynamic culturing (Dyn) and 2) static culturing (St). Firstly, hPSCs were cultured for two days in ultra-low attachment plates to develop spheroids. The spheroids were then transferred to pillar plates followed by direct cardiac differentiation the next day. Live-cell imaging was used to monitor the process of vascularization for up to 16 days and the corresponding fluorescence intensity of each cell type from its reporter expression was analyzed. The cardiac function was measured by video-based contractility analysis. Data were presented as mean ± standard error of the mean (SEM). The student’s t-test was used for the statistical analysis. Results: Cardiomyocytes (CMs) and endothelial cells (ECs) were imaged on pillars under the two conditions as shown in Fig. 1A . Successful cardiac differentiation was present, displaying hPSC-CM contraction on day 12 and onwards. Higher intensity values of hPSC-CMs under Dyn were observed in all four days compared to St as shown in Figs. 1B&C . The hPSC-ECs intensity displayed greater intensity values compared to St, demonstrating enhanced vascularization in VCOs due to the active Dyn as shown in Figs. 1D&E . The functionality was improved in Dyn as indicated with higher contraction velocity as shown in Fig. 1F. Conclusion: This study demonstrates the effects of incorporating dynamic culture for enhancing cardiogenesis and vasculogenesis in hPSC-derived COs. The enhanced hPSC-VCOs hold promise for studying early cardiovascular development, congenital heart disease modeling, and drug screening and discovery.

Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease

Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening.

Cardiac Organoid — a Promising Perspective of Preclinical Model

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Improving human cardiac organoid design using transcriptomics

Generation of Human Vascularized and Chambered Cardiac Organoids for Cardiac Disease Modelling and Drug Evaluation.

Self-Assembled Chambered Cardiac Organoids for Modeling Cardiac Chamber Formation and Cardiotoxicity Assessment

A Review of Protocols for Engineering Human Cardiac Organoids.

Self-assembly vascularized human cardiac organoids model cardiac diseases in petri dishes and in mice

Advances in Cardiac Organoids

Single-cell Atlas of Multilineage Cardiac Organoids Derived from Human Induced Pluripotent Stem Cells

Promises and Challenges of Cardiac Organoids

Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography

Revolutionizing Cardiovascular Research: Human Organoids as a Beacon of Hope for Understanding and Treating Cardiovascular Diseases

Unveiling New Horizons in Heart Research: the Promise of Multi-Chamber Cardiac Organoids

Organoid technology for tissue engineering

A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization

Micropatterned Organoids Enable Modeling of the Earliest Stages of Human Cardiac Vascularization

Abstract We047: Enhanced Vascularization in hPSC-derived Cardiac Organoids by Dynamic Culture

Human heart-forming organoids recapitulate early heart and foregut development

Engineered platforms for mimicking cardiac development and drug screening